| BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice JW Voncken, V Kaartinen, PK Pattengale, WT Germeraad, J Groffen, ... | 308 | 1995 |
| Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease MJE Havenga, AAC Lemckert, O Ophorst, M Van Meijer, WTV Germeraad, ... Journal of virology 76 (9), 4612-4620, 2002 | 288 | 2002 |
| Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy Y Gong, RGJ Klein Wolterink, J Wang, GMJ Bos, WTV Germeraad Journal of hematology & oncology 14 (1), 73, 2021 | 257 | 2021 |
| Influence of vitamin C on lymphocytes: an overview GNY Van Gorkom, RGJ Klein Wolterink, CHMJ Van Elssen, L Wieten, ... Antioxidants 7 (3), 41, 2018 | 192 | 2018 |
| Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells S Sarkar, WTV Germeraad, KMA Rouschop, EMP Steeghs, M Gelder, ... PloS one 8 (5), e64835, 2013 | 183 | 2013 |
| Thymic microenvironments, 3-D versus 2-D? W Van Ewijk, BP Wang, G Hollander, H Kawamoto, E Spanopoulou, M Itoi, ... Seminars in immunology 11 (1), 57-64, 1999 | 174 | 1999 |
| Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments W Van Ewijk, J De Kruif, WTV Germeraad, P Berendes, C Röpke, ... Proceedings of the National Academy of Sciences 94 (8), 3903-3908, 1997 | 132 | 1997 |
| Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells MJAJ Huijskens, M Walczak, N Koller, JJ Briedé, BLMG Senden-Gijsbers, ... Journal of Leukocyte Biology 96 (6), 1165-1175, 2014 | 130 | 2014 |
| Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy S Cloosen, J Arnold, M Thio, GMJ Bos, B Kyewski, WTV Germeraad Cancer research 67 (8), 3919-3926, 2007 | 118 | 2007 |
| Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects CML Zegers, NH Rekers, DHF Quaden, NG Lieuwes, A Yaromina, ... Clinical cancer research 21 (5), 1151-1160, 2015 | 111 | 2015 |
| Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia RK Jellema, TGAM Wolfs, V Lima Passos, A Zwanenburg, ... PLoS one 8 (8), e73031, 2013 | 108 | 2013 |
| Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep RK Jellema, V Lima Passos, A Zwanenburg, DRMG Ophelders, ... Journal of neuroinflammation 10, 1-19, 2013 | 105 | 2013 |
| Ascorbic acid serum levels are reduced in patients with hematological malignancies MJAJ Huijskens, WKWH Wodzig, M Walczak, WTV Germeraad, GMJ Bos Results in immunology 6, 8-10, 2016 | 101 | 2016 |
| Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy MJAJ Huijskens, M Walczak, S Sarkar, F Atrafi, BLMG Senden-Gijsbers, ... Cytotherapy 17 (5), 613-620, 2015 | 98 | 2015 |
| Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer CHMJ Van Elssen, PWH Frings, FJ Bot, KK Van de Vijver, MB Huls, ... Histopathology 57 (4), 597-606, 2010 | 98 | 2010 |
| Inflammation restraining effects of prostaglandin E2 on natural killer–dendritic cell (NK-DC) interaction are imprinted during DC maturation CHMJ Van Elssen, J Vanderlocht, T Oth, BLMG Senden-Gijsbers, ... Blood, The Journal of the American Society of Hematology 118 (9), 2473-2482, 2011 | 87 | 2011 |
| Natural killer cells: the secret weapon in dendritic cell vaccination strategies CHMJ Van Elssen, T Oth, WTV Germeraad, GMJ Bos, J Vanderlocht Clinical Cancer Research 20 (5), 1095-1103, 2014 | 64 | 2014 |
| Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A S Sarkar, M van Gelder, W Noort, Y Xu, KMA Rouschop, R Groen, ... Cancer Immunology, Immunotherapy 64, 951-963, 2015 | 63 | 2015 |
| Human binding molecule against CD1a M Throsby, M Van Meijer, WTV Germeraad, RJ Arceci, AM Kruisbeek US Patent 7,968,092, 2011 | 58 | 2011 |
| Fractionated radiotherapy with 3 x 8 Gy induces systemic anti-tumour responses and abscopal tumour inhibition without modulating the humoral anti-tumour response THPM Habets, T Oth, AW Houben, MJAJ Huijskens, ... PloS one 11 (7), e0159515, 2016 | 56 | 2016 |
